Although not studied extensively, there have been traces of semaglutide found in the breast milk, through animal studies
Patients with a personal or family history of medullary thyroid carcinoma should not take semaglutide, as animal studies have shown an association between GLP-1 agonists and thyroid C-cell tumors
However, it's essential to remember that these symptoms often subside as your body gets used to semaglutide
Quick Answer: Lack of results with semaglutide at lower doses typically reflects insufficient time at therapeutic levels, subtherapeutic dosing, or individual variability requiring dose escalation
For patients who do not have insurance or whose insurance does not cover the cost of medication, our weight loss program in University of California-Santa Barbara, California offers affordable self-pay options for accessing visits and medications
The GI symptom spectrum The FDA prescribing information for Wegovy lists the following GI side effect rates at the 2.4mg dose: Nausea: 44% of patients